Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Cyclerion Therapeutics, Inc. (CYCN) had Normalized Pre-Tax Income of $-3.06M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$2.00M |
|
$-3.06M |
|
-- |
|
$2.00M |
|
$5.63M |
|
$-3.63M |
|
$0.57M |
|
$-3.06M |
|
|
Normalized Pre-Tax Income |
$-3.06M |
$-3.06M |
|
$-3.06M |
|
$-3.06M |
|
$-3.06M |
|
$-3.63M |
|
$-3.63M |
|
2.52M |
|
2.52M |
|
$-1.21 |
|
$-1.21 |
|
| Balance Sheet Financials | |
$4.22M |
|
-- |
|
$5.35M |
|
$9.57M |
|
$0.72M |
|
-- |
|
-- |
|
$0.72M |
|
$8.85M |
|
$8.85M |
|
$8.85M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-4.33M |
|
$0.00M |
|
$0.00M |
|
$7.57M |
|
$3.23M |
|
$-4.34M |
|
$0.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-181.40% |
|
-181.40% |
|
-181.40% |
|
-152.85% |
|
-152.85% |
|
$-4.33M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
3.60 |
|
101.47 |
|
-34.54% |
|
-34.54% |
|
-31.93% |
|
-34.54% |
|
$3.48 |
|
$-1.72 |
|
$-1.72 |
|